CDXS stock · CLOV stock

CDXS vs CLOV

Codexis Inc (CDXS) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.

Codexis Inc (CDXS) is a biotechnology company listed on US.

Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.

Latest reported CDXS revenue for 2024-12-31 was $59.3M. Net income was -$65.3M. Revenue was down 15.4% from 2023-12-31 to 2024-12-31. CDXS currently screens at market cap $257.6M.

Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.

CDXS currently screens at market cap $257.6M. CLOV currently screens at market cap $1.55B.

Not investment advice. Open the CDXS and CLOV stock pages for the full models.

Not investment advice.

Popular Stock Comparisons